Loading clinical trials...
Loading clinical trials...
A Phase 2a, Multi-centre, Placebo Controlled, Randomized, Assessor Blind Study of Bolus 5-fluorouracil and Infused Leucovorin Plus Either Infused TK-90 for Parenteral Use or Infused TK-90 Placebo Administered Weekly for 6 Consecutive Weeks to Patients With Colorectal Cancer.
Conditions
Interventions
TK-112690
Placebo
Locations
5
India
Jawaharlal Nehru Cancer Hospital and Research Centre
Bhopal, Madhya Pradesh, India
Om Sai Onco Surgery Multispecialty Hospital Center
Kolhāpur, Maharashtra, India
B. J. Medical College and Sassoon General Hospital
Pune, Maharashtra, India
MTES Sanjeevan Hospital
Pune, Maharashtra, India
Saveetha Medical college Chennai
Chennai, Tamil Nadu, India
Start Date
June 15, 2022
Primary Completion Date
September 1, 2023
Completion Date
September 1, 2023
Last Updated
August 14, 2023
NCT05853692
NCT06305000
NCT03983369
NCT07040969
NCT07047261
NCT06968520
Lead Sponsor
Tosk, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions